+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shionogi and Co ltd - logo

Shionogi develops pharmaceutical products for pain, pediatric conditions, infectious diseases, cardiovascular diseases, diabetes, and women's health. It offers products in the form of injections, chewable and oral tablets, capsules, and oral suspensions. It has been expanding its pipeline and its portfolio of marketed products to encompass other therapeutic areas as well, with programs in metabolic conditions and pain management. The company was founded in 2010 and is based in Florham Park, New Jersey.

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Influenza Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2022 to 2030 - Product Thumbnail Image

Influenza Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2022 to 2030

  • Report
  • August 2022
  • 117 Pages
  • Global
From
Infectious Disease Therapeutics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel - Product Thumbnail Image

Infectious Disease Therapeutics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel

  • Report
  • January 2024
  • 193 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 319 Pages
  • Global
From
Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 734 Pages
  • Global
From
Opioid Induced Constipation Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Opioid Induced Constipation Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 100 Pages
  • Global
From
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 643 Pages
  • Global
From
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2020 - Product Thumbnail Image

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 187 Pages
  • Global
From
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2020 - Product Thumbnail Image

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 207 Pages
  • Global
From
Global Central Nervous System (CNS) Stimulant Drugs Market 2023-2027 - Product Thumbnail Image

Global Central Nervous System (CNS) Stimulant Drugs Market 2023-2027

  • Report
  • February 2023
  • 161 Pages
  • Global
From
Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 150 Pages
  • Global
From
Global Peripheral Neuropathy Treatment Market 2023-2027 - Product Thumbnail Image

Global Peripheral Neuropathy Treatment Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
P2X Purinoceptor 3 - Pipeline Review, H1 2020 - Product Thumbnail Image

P2X Purinoceptor 3 - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 67 Pages
  • Global
From
Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 746 Pages
  • Global
From
Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021 - Product Thumbnail Image

Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021

  • Report
  • July 2021
  • 178 Pages
  • Global
From
Sepsis - Pipeline Insight, 2024 - Product Thumbnail Image

Sepsis - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 80 Pages
  • Global
From
Systemic Aspergillosis and Systemic Candidiasis Global Market Report 2024 - Product Thumbnail Image

Systemic Aspergillosis and Systemic Candidiasis Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Pseudomonas Aeruginosa Infection Treatment Global Market Report 2024 - Product Thumbnail Image

Pseudomonas Aeruginosa Infection Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Gram-Positive Bacterial Infections Market - Growth, Trends and Forecasts (2023-2028) - Product Thumbnail Image

Gram-Positive Bacterial Infections Market - Growth, Trends and Forecasts (2023-2028)

  • Report
  • April 2023
  • 114 Pages
  • Global
From
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 2271 Pages
  • Global
From
Loading Indicator